Inhaltsverzeichnis
Introduction: Regenerative Medicine for Cardiovascular Disease-A Good Start PART I: STEM CELLS: Chapter 1: Introduction and Overview of Stem CellsChapter 2: Mechanistic Insights from Pathologic Perspective Chapter 3: Large Animal Models to Study Stem Cell TherapySection I. Body's Native Repair MechanismsChapter 4. Evolution of understanding of the mechanisms of repair Chapter 5: Impact of Age on Stem Cell FunctionSection II: Autologous Bone MarrowChapter 6: Bone Marrow Mononuclear CellsChapter 7: Chronic Limb IschemiaChapter 8: Chronic/Refractory AnginaChapter 9: Acute Myocardial InfarctionA. European Experience: Andreas ZeiherB. US Experience: Jay Traverse Chapter 10: Chronic Ischemic Heart FailureSection III: Autologous Adipose Derived Regenerative CellsChapter 11: Adipose TissueSection IV: Allogeneic Alternatives to Autologous Bone MarrowChapter 12: Overview of MSCs Chapter 13: Allogeneic vs Autologous Source: Comparative EffectsChapter 14: Use of MSCs for AMIChapter 15: Combined Cell StrategiesChapter 16: Heart FailureSection V: Cardiac Progenitor CellsChapter 17: C-Kit+ cellsChapter 18: CardiospheresSection VI: Other Allogeneic Sources of Stem CellsChapter 19: Umbilical Cord, Placenta, EndometriumSection VII. Genetic Engineering/Cell TransformationChapter 20: Genetic Engineering of Fibroblasts to CardiomyocytesChapter 21: Transformation to inducible Pleuripotent Stem CellsChapter 22: Transformation to MAPC'sSection VIII: METHODS OF DELIVERY: Chapter 23. Transcoronary and EndocardialChapter 24. Retrograde and EpicardialPart II. TISSUE ENGINEERING:Chapter 25. Epicardial PatchChapter 26. Matrix ScaffoldsChapter 27. Matrix plus cellsChapter 28. BiomaterialChapter 29: OrganogenesisPart III. GENE THERAPY: Chapter 30: Pre-clinical Identification of target genesChapter 31: SERCA-2a gene for recovery of inotropic functionChapter 32: SDF-1 Gene for Heart Failure Non-Inotropic MechanismsChapter 33: Gene Therapy for Angiogenesis: Chronic Limb Ischemia Chapter 34: Stem Cells Target Gene Transfected Stem CellsPart IV: FUTURE DIRECTIONS:Chapter 35: CCTRN: Past, Present, and Vision for the FutureChapter 36: Signature of Responders-lessons from Bio-RepositoryChapter 37: Adjunctive therapy with LVADs for RecoveryChapter 38: Trials in Non-Ischemic Heart Failure Chapter 39: Enhancing Stem Cell Homing for Tissue RepairChapter 40: Stroke: Pre-Clinical and Clinical Trial DataSUMMARY